default author photo

Amer Mahmood

King Saud University - Cancer Stem Cell Group

Riyadh

Saudi Arabia

  • King Saud University - Cancer Stem Cell Group

SCHOLARLY PAPERS

4

DOWNLOADS

262

TOTAL CITATIONS

0

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Employing Integrated Omics, Artificial Intelligence and Machine learning Tools for Refined Stratification of Blast Crisis CML Patients via Genetic clustering and COSMIC Mutational Signatures: A Practical Framework for Precision Repurposing of FDA/EMA-Approved Anti-Cancer Drugs in Refractory Cancers post-COVID19

No
Number of pages: 15 Posted: 24 Jul 2025
Dr Abdulkareem Algarni MD, Nawaf Alanzazi, Sarah AlMukhaylid, Sultan Al Qahtani, Hassan Almasoudi, Yaqob Taleb, Nada Alkhamis, Amer Mahmood, Tayyib Hussain, Sameerah Shaheen, Abdulaziz Siyal, Aamer Aleem, Riazul Haq, Rizwan Naeem, Masood Shammas, Giuseppe Saglio, Norah Algarzae, Deema Alroweilly and Dr. Zafar Iqbal
King Abdulaziz Hospital, King Abdulaziz Hospital, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Hospital, Najran University, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, King Saud University - Cancer Stem Cell Group, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, King Saud University, Riyadh, Saudia Arabia, King Saud University - Cancer Stem Cell Group, King Saud University Medical City, University of Texas Health Science Center at San Antonio, Albert Einstein College of Medicine, Department of Medical Oncology, Harvard (Dana Farber) Cancer Institute, University of Turin, King Saud University, Riyadh, Saudia Arabia, King Saud University, Riyadh, Saudia Arabia and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs
Downloads 123 (584,619)

Abstract:

Loading...

Blast Crisis CML Precision Therapy, Pan-Cancer Genomic Stratification, AI-Guided Drug Repurposing, COSMIC Signature-Driven Oncology, Machine Learning in Leukemia Treatment

2.

Metabolic and Nutritional Mutation Signatures Drive Early Progression of Chronic Myeloid Leukemia: A Whole-Exome and AI-Guided Precision Framework

No
Number of pages: 22 Posted: 29 Jul 2025
Dr. Zafar Iqbal, Sarah AlMukhaylid, Masood Shammas, Sultan Al Qahtani, Dr Abdulkareem Algarni MD, Aamer Aleem, Nawaf Alanzazi, Yaqob Taleb, Rizwan Naeem, Amer Mahmood and Giuseppe Saglio
King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, Department of Medical Oncology, Harvard (Dana Farber) Cancer Institute, King Abdulaziz Hospital, King Abdulaziz Hospital, King Saud University Medical City, King Abdulaziz Hospital, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Albert Einstein College of Medicine, King Saud University - Cancer Stem Cell Group and University of Turin
Downloads 57 (989,921)

Abstract:

Loading...

CML, Disease progression, Metabolic signatures, FADS6 gene, Cancer and metabolism

3.

Utilization of targeted resequencing for clinical validation of mutated FANCD2 gene as a promising molecular biomarker of early disease progression in Saudi Chronic Myeloid Leukemia: A case-control study

Number of pages: 20 Posted: 19 Dec 2023 Last Revised: 07 Mar 2024
Nawaf Alanzazi, Abdulaziz Siyal, Salman Basit, Masood Shammas, Amer Mahmood, Sarah AlMukhaylid and Dr. Zafar Iqbal
King Abdulaziz Hospital, King Saud University - Cancer Stem Cell Group, Center for Genetics and Inherited Diseases, Taibah University Madinah., Department of Medical Oncology, Harvard (Dana Farber) Cancer Institute, King Saud University - Cancer Stem Cell Group, King Saud Bin Abdulaziz University for Health Sciences and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs
Downloads 57 (989,921)

Abstract:

Loading...

Chronic Myeloid Leukemia, CML progression, Poor Survival, Genomic Instability, DNA Repair, FANCD2

4.

Next-generation DNA sequences identifies mutated FANCD2 Gene as a novel Biomarker for early disease progression in Chronic Myeloid Leukemia patients

Number of pages: 20 Posted: 19 Dec 2023
Nawaf Alanzazi, Abdulaziz Siyal, Muhammad Absar, Amer Mahmood, Masood Shammas, Sarah AlMukhaylid and Dr. Zafar Iqbal
King Abdulaziz Hospital, King Saud University - Cancer Stem Cell Group, King Abdulaziz Hospital, King Saud University - Cancer Stem Cell Group, Department of Medical Oncology, Harvard (Dana Farber) Cancer Institute, King Saud Bin Abdulaziz University for Health Sciences and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs
Downloads 25 (1,385,945)

Abstract:

Loading...

Chronic Myeloid Leukemia, CML progression, poor survival, genomic instability, DNA repair, FANCD2